Restricted access
Review articles
Review articles
A perspective on Notch signalling in progression and arrhythmogenesis in familial hypertrophic and dilated cardiomyopathies
Published:01 May 2023https://doi.org/10.1098/rstb.2022.0176
Abstract
In this perspective, we discussed emerging data indicating a role for Notch signalling in inherited disorders of the heart failure with focus on hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) linked to variants of genes encoding mutant proteins of the sarcomere. We recently reported an upregulation of elements in the Notch signalling cascade in cardiomyocytes derived from human inducible pluripotent stem cells expressing a TNNT2 variant encoding cardiac troponin T (cTnT-I79N+/−), which induces hypertrophy, remodelling, abnormalities in excitation–contraction coupling and electrical instabilities (Shafaattalab S et al. 2021 Front. Cell Dev. Biol. 9, 787581. (doi:10.3389/fcell.2021.787581)). Our search of the literature revealed the novelty of this finding and stimulated us to discuss potential connections between the Notch signalling pathway and familial cardiomyopathies. Our considerations focused on the potential role of these interactions in arrhythmias, microvascular ischaemia, and fibrosis. This finding underscored a need to consider the role of Notch signalling in familial cardiomyopathies which are trigged by sarcomere mutations engaging mechano-signalling pathways for which there is evidence of a role for Notch signalling with crosstalk with Hippo signalling. Our discussion included a role for both cardiac myocytes and non-cardiac myocytes in progression of HCM and DCM.
This article is part of the theme issue ‘The heartbeat: its molecular basis and physiological mechanisms’.
Footnotes
References
- 1.
Shafaattalab S 2021 Mechanisms of arrhythmogenicity of hypertrophic cardiomyopathy-associated troponin T (TNNT2) variant I79N. Front. Cell Dev. Biol. 9, 787581. (doi:10.3389/fcell.2021.787581) Crossref, PubMed, ISI, Google Scholar - 2.
De La Pompa JL, Epstein JA . 2012 Coordinating tissue interactions: Notch signaling in cardiac development and disease. Dev. Cell. 22, 244-254. (doi:10.1016/j.devcel.2012.01.014) Crossref, PubMed, ISI, Google Scholar - 3.
Stassen O, Ristori T, Sahlgren CM . 2020 Notch in mechanotransduction - from molecular mechanosensitivity to tissue mechanostasis. J. Cell Sci. 133, jcs250738. (doi:10.1242/jcs.250738) Crossref, PubMed, ISI, Google Scholar - 4.
Niessen K, Karsan A . 2008 Notch signaling in cardiac development. Circ. Res. 102, 1169-1181. (doi:10.1161/CIRCRESAHA.108.174318) Crossref, PubMed, ISI, Google Scholar - 5.
Meloty-Kapella L, Shergill B, Kuon J, Botvinick E, Weinmaster G . 2012 Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin. Dev. Cell 22, 1299-1312. (doi:10.1016/j.devcel.2012.04.005) Crossref, PubMed, ISI, Google Scholar - 6.
Luca VC 2017 Notch-Jagged complex structure implicates a catch bond in tuning ligand sensitivity. Science 355, 1320-1324. (doi:10.1126/science.aaf9739) Crossref, PubMed, ISI, Google Scholar - 7.
Esteves De Lima J, Bonnin MA, Birchmeier C, Duprez D . 2016 Muscle contraction is required to maintain the pool of muscle progenitors via YAP and NOTCH during fetal myogenesis. Elife 5, e15593. (doi:10.7554/eLife.15593) Crossref, PubMed, ISI, Google Scholar - 8.
Miyagawa K 2019 Smooth muscle contact drives endothelial regeneration by BMPR2-Notch1-mediated metabolic and epigenetic changes. Circ. Res. 124, 211-224. (doi:10.1161/CIRCRESAHA.118.313374) Crossref, PubMed, ISI, Google Scholar - 9.
Dieseldorff Jones KM, Vied C, Valera IC, Chase PB, Parvatiyar MS, Pinto JR . 2020 Sexual dimorphism in cardiac transcriptome associated with a troponin C murine model of hypertrophic cardiomyopathy. Physiol. Rep. 8, e14396. (doi:10.14814/phy2.14396) Crossref, PubMed, ISI, Google Scholar - 10.
Hannigan GE, Coles JG, Dedhar S . 2007 Integrin-linked kinase at the heart of cardiac contractility, repair, and disease. Circ. Res. 100, 1408-1414. (doi:10.1161/01.RES.0000265233.40455.62) Crossref, PubMed, ISI, Google Scholar - 11.
Byun J, Del Re DP, Zhai P, Ikeda S, Shirakabe A, Mizushima W, Miyamoto S, Brown JH, Sadoshima J . 2019 Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload. J. Biol. Chem. 294, 3603-3617. (doi:10.1074/jbc.RA118.006123) Crossref, PubMed, ISI, Google Scholar - 12.
Wang P 2014 The alteration of Hippo/YAP signaling in the development of hypertrophic cardiomyopathy. Basic Res. Cardiol. 109, 435. (doi:10.1007/s00395-014-0435-8) Crossref, PubMed, ISI, Google Scholar - 13.
Hou N, Wen Y, Yuan X, Xu H, Wang X, Li F, Ye B . 2017 Activation of Yap1/Taz signaling in ischemic heart disease and dilated cardiomyopathy. Exp. Mol. Pathol. 103, 267-275. (doi:10.1016/j.yexmp.2017.11.006) Crossref, PubMed, ISI, Google Scholar - 14.
Norum HM 2017 The Notch ligands DLL1 and periostin are associated with symptom severity and diastolic function in dilated cardiomyopathy. J Cardiovasc. Transl. Res. 10, 401-410. (doi:10.1007/s12265-017-9748-y) Crossref, PubMed, ISI, Google Scholar - 15.
Kuzmanov U, Guo H, Buchsbaum D, Cosme J, Abbasi C, Isserlin R, Sharma P, Gramolini AO, Emili A . 2016 Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy. Proc. Natl Acad. Sci. USA 113, 12 592-12 597. (doi:10.1073/pnas.1606444113) Crossref, ISI, Google Scholar - 16.
Knollmann BC 2003 Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling. Circ. Res. 92, 428-436. (doi:10.1161/01.RES.0000059562.91384.1A) Crossref, PubMed, ISI, Google Scholar - 17.
Baudenbacher F, Schober T, Pinto JR, Sidorov VY, Hilliard F, Solaro RJ, Potter JD, Knollmann BC . 2008 Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J. Clin. Invest. 118, 3893-3903. (doi:10.1172/jci36642) PubMed, ISI, Google Scholar - 18.
Solís C, Solaro RJ . 2021 Novel insights into sarcomere regulatory systems control of cardiac thin filament activation. J. Gen. Physiol. 153, e202012777. (doi:10.1085/jgp.202012777) Crossref, PubMed, ISI, Google Scholar - 19.
Viola HM, Hool LC . 2019 Impaired calcium handling and mitochondrial metabolic dysfunction as early markers of hypertrophic cardiomyopathy. Arch. Biochem. Biophys. 665, 166-174. (doi:10.1016/j.abb.2019.03.006) Crossref, PubMed, ISI, Google Scholar - 20.
Fraysse B 2012 Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J. Mol. Cell. Cardiol. 52, 1299-1307. (doi:10.1016/j.yjmcc.2012.03.009) Crossref, PubMed, ISI, Google Scholar - 21.
Zhang J, Wang L, Kazmierczak K, Yun H, Szczesna-Cordary D, Kawai M . 2021 Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca(2+) sensitivity. FEBS J. 288, 4596-4613. (doi:10.1111/febs.15753) Crossref, PubMed, Google Scholar - 22.
Palmer BM 2008 Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. Am. J. Physiol. Heart Circ. Physiol. 294, H1939-H1947. (doi:10.1152/ajpheart.00644.2007) Crossref, PubMed, ISI, Google Scholar - 23.
Solaro RJ . 2022 Advances in understanding the state of titin truncation variants in dilated cardiomyopathy. Pflügers Archiv – Eur. J. Physiol. 474, 265-266. (doi:10.1007/s00424-022-02664-0) Crossref, PubMed, ISI, Google Scholar - 24.
Goldspink PH, Warren CM, Kitajewski J, Wolska BM, Solaro RJ . 2021 A perspective on personalized therapies in hypertrophic cardiomyopathy. J. Cardiovasc. Pharmacol. 77, 317-322. (doi:10.1097/FJC.0000000000000968) Crossref, PubMed, ISI, Google Scholar - 25.
Larson A, Codden CJ, Huggins GS, Rastegar H, Chen FY, Maron BJ, Rowin EJ, Maron MS, Chin MT . 2022 Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy. Sci. Rep. 12, 5211. (doi:10.1038/s41598-022-08561-x) Crossref, PubMed, ISI, Google Scholar - 26.
Wehrens M 2022 Single-cell transcriptomics provides insights into hypertrophic cardiomyopathy. Cell Rep. 39, 110809. (doi:10.1016/j.celrep.2022.110809) Crossref, PubMed, ISI, Google Scholar - 27.
Caolo V, Debant M, Endesh N, Futers TS, Lichtenstein L, Bartoli F, Parsonage G, Jones EAV, Beech DJ . 2020 Shear stress activates ADAM10 sheddase to regulate Notch1 via the Piezo1 force sensor in endothelial cells. Elife 9, e50684. (doi:10.7554/eLife.50684) Crossref, PubMed, ISI, Google Scholar - 28.
Lu YW, Martino N, Gerlach BD, Lamar JM, Vincent PA, Adam AP, Schwarz JJ . 2021 MEF2 (Myocyte Enhancer Factor 2) is essential for endothelial homeostasis and the atheroprotective gene expression program. Arterioscler. Thromb. Vasc. Biol. 41, 1105-1123. (doi:10.1161/ATVBAHA.120.314978) Crossref, PubMed, ISI, Google Scholar - 29.
Wang L, Kryshtal DO, Kim K, Parikh S, Cadar AG, Bersell KR, He H, Pinto JR, Knollmann BC . 2017 Myofilament calcium-buffering dependent action potential triangulation in human-induced pluripotent stem cell model of hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 70, 2600-2602. (doi:10.1016/j.jacc.2017.09.033) Crossref, PubMed, ISI, Google Scholar - 30.
Alves ML 2014 Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins. Circ. Cardiovasc. Genet. 7, 132-143. (doi:10.1161/CIRCGENETICS.113.000324) Crossref, PubMed, Google Scholar - 31.
Alves ML, Warren CM, Simon JN, Gaffin RD, Montminy EM, Wieczorek DF, Solaro RJ, Wolska BM . 2017 Early sensitization of myofilaments to Ca2+ prevents genetically linked dilated cardiomyopathy in mice. Cardiovasc. Res. 113, 915-925. (doi:10.1093/cvr/cvx068) Crossref, PubMed, ISI, Google Scholar - 32.
Cannon L 2015 Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period. J. Am. Coll. Cardiol. 65, 560-569. (doi:10.1016/j.jacc.2014.10.069) Crossref, PubMed, ISI, Google Scholar - 33.
Heras-Bautista CO 2019 Cardiomyocytes facing fibrotic conditions re-express extracellular matrix transcripts. Acta Biomater. 89, 180-192. (doi:10.1016/j.actbio.2019.03.017) Crossref, PubMed, ISI, Google Scholar - 34.
Borghetti G 2018 Notch signaling modulates the electrical behavior of cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 314, H68-h81. (doi:10.1152/ajpheart.00587.2016) Crossref, PubMed, ISI, Google Scholar - 35.
Ramratnam M 2016 Gene-targeted mice with the human troponin T R141W mutation develop dilated cardiomyopathy with calcium desensitization. PLoS ONE 11, e0167681. (doi:10.1371/journal.pone.0167681) Crossref, PubMed, ISI, Google Scholar - 36.
Khandekar A, Springer S, Wang W, Hicks S, Weinheimer C, Diaz-Trelles R, Nerbonne JM, Rentschler S . 2016 Notch-mediated epigenetic regulation of voltage-gated potassium currents. Circ. Res. 119, 1324-1338. (doi:10.1161/CIRCRESAHA.116.309877) Crossref, PubMed, ISI, Google Scholar - 37.
Yu M, Liu Y, Xiang F, Li Y, Cullen D, Liao R, Beyer RP, Bammler TK, Chin MT . 2009 CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways. OMICS 13, 501-511. (doi:10.1089/omi.2009.0086) Crossref, PubMed, ISI, Google Scholar - 38.
Pahlavani HA . 2022 Exercise-induced signaling pathways to counteracting cardiac apoptotic processes. Front. Cell Dev. Biol. 10, 950927. (doi:10.3389/fcell.2022.950927) Crossref, PubMed, ISI, Google Scholar - 39.
Chakravarti B, Yang J, Ahlers-Dannen KE, Luo Z, Flaherty HA, Meyerholz DK, Anderson ME, Fisher RA . 2017 Essentiality of regulator of G protein signaling 6 and oxidized Ca(2+)/calmodulin-dependent protein kinase II in notch signaling and cardiovascular development. J. Am. Heart Assoc. 6, e007038. (doi:10.1161/JAHA.117.007038) Crossref, PubMed, ISI, Google Scholar - 40.
Kirk JA, Kass DA . 2015 Cellular and molecular aspects of dyssynchrony and resynchronization. Card Electrophysiol. Clin. 7, 585-597. (doi:10.1016/j.ccep.2015.08.011) Crossref, PubMed, Google Scholar - 41.
Nordin H, Nakagawa R, Wallin M, Pernow J, Kass DA, Ståhlberg M . 2020 Regional protein expression changes within the left ventricle in a mouse model of dyssynchronous and resynchronized heart failure. ESC Heart Fail. 7, 4438-4442. (doi:10.1002/ehf2.13038) Crossref, PubMed, ISI, Google Scholar - 42.
Ferreira JP 2020 Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE-HF trial. ESC Heart Fail. 7, 503-511. (doi:10.1002/ehf2.12521) Crossref, PubMed, ISI, Google Scholar - 43.
Jiang W, Liu Y, He Z, Zhou Y, Wang C, Jiang Z, Zhou W . 2021 Prognostic value of left ventricular mechanical dyssynchrony in hypertrophic cardiomyopathy patients with low risk of sudden cardiac death. Nucl. Med. Commun. 42, 182-189. (doi:10.1097/MNM.0000000000001322) Crossref, PubMed, ISI, Google Scholar - 44.
Maron BJ, Maron MS, Maron BA, Loscalzo J . 2019 Moving beyond the sarcomere to explain heterogeneity in hypertrophic cardiomyopathy: JACC review topic of the week. J. Am. Coll. Cardiol. 73, 1978-1986. (doi:10.1016/j.jacc.2019.01.061) Crossref, PubMed, ISI, Google Scholar - 45.
Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A . 2000 Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum. Pathol. 31, 988-998. (doi:10.1053/hupa.2000.16659) Crossref, PubMed, ISI, Google Scholar - 46.
Cecchi F, Sgalambro A, Baldi M, Sotgia B, Antoniucci D, Camici PG, Sciagrã R, Olivotto I . 2009 Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy. J. Cardiovasc. Transl. Res. 2, 452-461. (doi:10.1007/s12265-009-9142-5) Crossref, PubMed, ISI, Google Scholar - 47.
Foã A 2019 Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy. Int. J. Cardiol. 291, 77-82. (doi:10.1016/j.ijcard.2019.03.060) Crossref, PubMed, ISI, Google Scholar - 48.
Jablonowski R, Fernlund E, Aletras AH, Engblom H, Heiberg E, Liuba P, Arheden H, Carlsson M . 2015 Regional stress-induced ischemia in non-fibrotic hypertrophied myocardium in young HCM patients. Pediatr. Cardiol. 36, 1662-1669. (doi:10.1007/s00246-015-1214-5) Crossref, PubMed, ISI, Google Scholar - 49.
Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ . 2012 Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J. Cardiovasc. Magn. Reson. 14, 76. (doi:10.1186/1532-429X-14-76) Crossref, PubMed, ISI, Google Scholar - 50.
Gyllenhammar T, Fernlund E, Jablonowski R, Jogi J, Engblom H, Liuba P, Arheden H, Carlsson M . 2014 Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR. Eur. Heart J. Cardiovasc. Imaging 15, 1350-1357. (doi:10.1093/ehjci/jeu137) Crossref, PubMed, ISI, Google Scholar - 51.
Malahfji M, Senapati A, Debs D, Angulo C, Zhan Y, Nagueh SF, Shah DJ . 2020 Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy. Sci. Rep. 10, 15977. (doi:10.1038/s41598-020-71394-z) Crossref, PubMed, ISI, Google Scholar - 52.
Del Gaudio F, Liu D, Lendahl U . 2022 Notch signalling in healthy and diseased vasculature. Open Biol. 12, 220004. (doi:10.1098/rsob.220004) Link, ISI, Google Scholar - 53.
O'Hare M, Arboleda-Velasquez JF . 2022 Notch signaling in vascular endothelial and mural cell communications. Cold Spring Harb. Perspect. Med. 12, a041159. (doi:10.1101/cshperspect.a041159) Crossref, PubMed, ISI, Google Scholar - 54.
Guo J, Mihic A, Wu J, Zhang Y, Singh K, Dhingra S, Weisel RD, Li R-K . 2015 Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy. Eur. Heart J. 36, 2530-2540. (doi:10.1093/eurheartj/ehv294) Crossref, PubMed, ISI, Google Scholar - 55.
Hershberger RE, Cowan J, Jordan E, Kinnamon DD . 2021 The complex and diverse genetic architecture of dilated cardiomyopathy. Circ. Res. 128, 1514-1532. (doi:10.1161/CIRCRESAHA.121.318157) Crossref, PubMed, ISI, Google Scholar - 56.
Hershberger RE 2009 Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. Circ. Cardiovasc. Genet. 2, 306-313. (doi:10.1161/CIRCGENETICS.108.846733) Crossref, PubMed, Google Scholar - 57.
Zhao H, Lv D, Zhang W, Dong W, Feng J, Xiang Z, Huang L, Qin C, Zhang L . 2010 Ginsenoside-Rb1 attenuates dilated cardiomyopathy in cTnTR141W transgenic mouse. J. Pharmacol. Sci. 112, 214-222. (doi:10.1254/jphs.09314FP) Crossref, PubMed, ISI, Google Scholar - 58.
Chaffin M 2022 Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy. Nature 608, 174-180. (doi:10.1038/s41586-022-04817-8) Crossref, PubMed, ISI, Google Scholar - 59.
Orphanou N, Papatheodorou E, Anastasakis A . 2022 Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments. Heart Fail. Rev. 27, 1173-1191. (doi:10.1007/s10741-021-10139-0) Crossref, PubMed, ISI, Google Scholar - 60.
Sato Y 2001 Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 103, 369-374. (doi:10.1161/01.CIR.103.3.369) Crossref, PubMed, ISI, Google Scholar - 61.
Coscarella IL, Landim-Vieira M, Pinto JR, Chelko SP . 2022 Arrhythmogenic cardiomyopathy: exercise pitfalls, role of connexin-43, and moving beyond antiarrhythmics. Int. J. Mol. Sci. 23, 8753. (doi:10.3390/ijms23158753) Crossref, PubMed, ISI, Google Scholar - 62.
Towbin JA, Lorts A . 2011 Arrhythmias and dilated cardiomyopathy common pathogenetic pathways? J. Am. Coll. Cardiol. 57, 2169-2171. (doi:10.1016/j.jacc.2010.11.061) Crossref, PubMed, ISI, Google Scholar - 63.
Peisker F 2022 Mapping the cardiac vascular niche in heart failure. Nat. Commun. 13, 3027. (doi:10.1038/s41467-022-30682-0) Crossref, PubMed, ISI, Google Scholar - 64.
Borysova L, Wray S, Eisner DA, Burdyga T . 2013 How calcium signals in myocytes and pericytes are integrated across in situ microvascular networks and control microvascular tone. Cell Calcium 54, 163-174. (doi:10.1016/j.ceca.2013.06.001) Crossref, PubMed, ISI, Google Scholar - 65.
Lee LL, Khakoo AY, Chintalgattu V . 2021 Cardiac pericytes function as key vasoactive cells to regulate homeostasis and disease. FEBS Open Bio. 11, 207-225. (doi:10.1002/2211-5463.13021) Crossref, PubMed, ISI, Google Scholar - 66.
Peppiatt CM, Howarth C, Mobbs P, Attwell D . 2006 Bidirectional control of CNS capillary diameter by pericytes. Nature 443, 700-704. (doi:10.1038/nature05193) Crossref, PubMed, ISI, Google Scholar - 67.
O'Farrell FM, Mastitskaya S, Hammond-Haley M, Freitas F, Wah WR, Attwell D . 2017 Capillary pericytes mediate coronary no-reflow after myocardial ischaemia. eLife. 6, e29280. (doi:10.7554/eLife.29280) Crossref, PubMed, ISI, Google Scholar - 68.
Le DE, Zhao Y, Kaul S . 2022 Persistent coronary vasomotor tone during myocardial ischemia occurs at the capillary level and may involve pericytes. Front. Cardiovasc. Med. 9, 930492. (doi:10.3389/fcvm.2022.930492) Crossref, PubMed, ISI, Google Scholar - 69.
Cheng J, Korte N, Nortley R, Sethi H, Tang Y, Attwell D . 2018 Targeting pericytes for therapeutic approaches to neurological disorders. Acta Neuropathol. 136, 507-523. (doi:10.1007/s00401-018-1893-0) Crossref, PubMed, ISI, Google Scholar - 70.
Alvino VV 2018 Transplantation of allogeneic pericytes improves myocardial vascularization and reduces interstitial fibrosis in a swine model of reperfused acute myocardial infarction. J. Am. Heart Assoc. 7, e006727. (doi:10.1161/JAHA.117.006727) Crossref, PubMed, ISI, Google Scholar - 71.
Alex L, Frangogiannis NG . 2019 Pericytes in the infarcted heart. Vasc. Biol. 1, H23-H31. (doi:10.1530/VB-19-0007) Crossref, PubMed, Google Scholar - 72.
Birbrair A, Zhang T, Files DC, Mannava S, Smith T, Wang Z-M, Messi ML, Mintz A, Delbono O . 2014 Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res. Ther. 5, 122. (doi:10.1186/scrt512) Crossref, PubMed, ISI, Google Scholar - 73.
Volz KS 2015 Pericytes are progenitors for coronary artery smooth muscle. eLife 4, e10036. (doi:10.7554/elife.10036) Crossref, PubMed, ISI, Google Scholar - 74.
Kerr BA 2016 Stability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endothelium. Nat. Commun. 7, 10960. (doi:10.1038/ncomms10960) Crossref, PubMed, ISI, Google Scholar - 75.
Nistri S, Sassoli C, Bani D . 2017 Notch signaling in ischemic damage and fibrosis: evidence and clues from the heart. Front. Pharmacol. 8, 187. (doi:10.3389/fphar.2017.00187) Crossref, PubMed, ISI, Google Scholar - 76.
Fan YH, Dong H, Pan Q, Cao YJ, Li H, Wang HC . 2011 Notch signaling may negatively regulate neonatal rat cardiac fibroblast-myofibroblast transformation. Physiol. Res. 60, 739-748. (doi:10.33549/physiolres.932149) Crossref, PubMed, ISI, Google Scholar - 77.
Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC . 2016 Cardiac fibrosis: the fibroblast awakens. Circ. Res. 118, 1021-1040. (doi:10.1161/CIRCRESAHA.115.306565) Crossref, PubMed, ISI, Google Scholar - 78.
Nemir M, Metrich M, Plaisance I, Lepore M, Cruchet S, Berthonneche C, Sarre A, Radtke F, Pedrazzini T . 2014 The Notch pathway controls fibrotic and regenerative repair in the adult heart. Eur. Heart J. 35, 2174-2185. (doi:10.1093/eurheartj/ehs269) Crossref, PubMed, ISI, Google Scholar - 79.
Gude NA 2008 Activation of Notch-mediated protective signaling in the myocardium. Circ. Res. 102, 1025-1035. (doi:10.1161/CIRCRESAHA.107.164749) Crossref, PubMed, ISI, Google Scholar - 80.
Marques MA 2021 Anomalous structural dynamics of minimally frustrated residues in cardiac troponin C triggers hypertrophic cardiomyopathy. Chem. Sci. 12, 7308-7323. (doi:10.1039/D1SC01886H) Crossref, PubMed, ISI, Google Scholar - 81.
Marijon E, Uy-Evanado A, Reinier K, Teodorescu C, Narayanan K, Jouven X, Gunson K, Jui J, Chugh SS . 2015 Sudden cardiac arrest during sports activity in middle age. Circulation 131, 1384-1391. (doi:10.1161/CIRCULATIONAHA.114.011988) Crossref, PubMed, ISI, Google Scholar - 82.
Pelliccia F, Limongelli G, Autore C, Gimeno-Blanes JR, Basso C, Elliott P . 2019 Sex-related differences in cardiomyopathies. Int. J. Cardiol. 286, 239-243. (doi:10.1016/j.ijcard.2018.10.091) Crossref, PubMed, ISI, Google Scholar - 83.
Gianni D 2010 Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy. Circulation 121, 1216-1226. (doi:10.1161/CIRCULATIONAHA.109.879510) Crossref, PubMed, ISI, Google Scholar - 84.
Li D 2006 Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am. J. Hum. Genet. 79, 1030-1039. (doi:10.1086/509900) Crossref, PubMed, ISI, Google Scholar - 85.
Nelson O, Tu H, Lei T, Bentahir M, De Strooper B, Bezprozvanny I . 2007 Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. J. Clin. Invest. 117, 1230-1239. (doi:10.1172/JCI30447) Crossref, PubMed, ISI, Google Scholar
